Search

everythinglearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TECAR therapy helps with pain relief, reduces inflammation, relaxes muscles, heals tissues, and is safe and effective for many conditions.

MK-5108 is safe and shows potential against tumors, especially alone.

Ethosomes can effectively deliver drugs deep into the skin, improving treatment for various skin conditions.

Ethosomes are effective, safe carriers for delivering drugs through the skin.

Hair regrowth improved, but quality of life did not.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

N13-substituted evodiamine derivatives improved anticancer activity and solubility, showing promise for drug development.

Triboelectric nanogenerators can use body movement to power therapeutic treatments, potentially transforming personalized healthcare.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

A man with lung cancer had skin and eye side effects from erlotinib but continued treatment with symptom improvement.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

The combined treatment effectively managed severe skin issues in Olmsted syndrome.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Microneedles can precisely deliver cancer treatments with fewer side effects.

The treatment combination is effective and generally safe for lung cancer.

Etanercept effectively treated a severe skin condition when other treatments failed.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Topical human epidermal growth factor may effectively treat acne caused by cancer medication.

Erlotinib can cause unexpected side effects like eyelash growth and scarring.